Ex vivo gene delivery of platelet-derived growth factor increases O-2A progenitors in adult rat spinal cord

Gene Therapy

Volumn 3, Issue 5, 1996, Pages 389-395

  Ijichi, A ^a   Noel, F ^a   Sakuma, S ^a   Weil, M M ^a   Tofilon, P J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Ex vivo gene therapy; O 2A progenitor; PDGF; Remyelination; Spinal cord

Indexed keywords

PLATELET DERIVED GROWTH FACTOR A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CERVICAL SPINAL CORD; CISTERNA MAGNA; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE TARGETING; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; SPINAL CORD; STEM CELL; SUBARACHNOID SPACE;

ANIMALS; CELL COUNT; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; STEM CELLS;

EID: 0030014849     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Schultheiss TE, Stephens LC. Permanent radiation myelopathy. Br J Radiol 1992; 65: 737-753.
2. Schultze B, Korr H. Cell kinetic studies of different cell types in the developing and adult brain of the rat and the mouse: a review. Cell Tissue Kinet 1981; 14: 309-325.
3. Raff M, Miller R, Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 1983; 303: 390-396.
4. van der Maazen RWM, Verhagen I, van der Kogel AJ. An in vivo-in vitro colony assay to assess radiation damage in rat CNS glial progenitor cells. Int J Radiat Biol 1990; 58: 835-844.
5. van der Maazen RWM, Verhagen I, Kleiboer BJ, van der Kogel AJ. Radiosensitivity of glial progenitor cells of the perinatal and adult rat optic nerve studied by an in vitro clonogenic assay. Radiother Oncol 1991; 20: 258-264.
6. Noble M et al. PDGF promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 1988; 333: 560-562.
7. Richardson W et al. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 1988; 53: 309-319.
8. Hart I et al. PDGF receptors on cells of the oligodendrocyte-type-2 astrocyte (O-2A) cell lineage. Development 1989; 105: 595-603.
9. Lotan M, Schwartz M. Post-injury changes in platelet-derived growth factor-like activity in fish and rat optic nerve. J Neurochem 1992; 58: 1637-1642.
10. Takayama S et al. Platelet-derived growth factor B-chain-like immunoreactivity in injured rat brain. Brain Res 1994; 653: 131-140.
11. Wolswijk G, Noble M. Cooperation between PDGF and FGF converts slowly dividing O-2A (adult) progenitor cells to rapidly dividing cells with characteristics of O-2A (perinatal) progenitor cells. J Cell Biol 1992; 118: 889-900.
12. Barres BA et al. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 1992; 70: 31-46.
13. Witte L et al. Effects of irradiation on the release of growth factor from cultured bovine, porcine, and human endothelial cells. Cancer Res 1989; 49: 5066-5072
14. Wolswijk G, Noble M. Identification of an adult-specific glial progenitor cell. Development 1989; 105: 387-400.
15. Blakemore W, Franklin R, Crang A. Repair of demyelinated lesions by glial cell transplantation. J Neurol 1994; 241: S61-S63.
16. Duncan I et al. Transplantation of oligodendrocytes and Schwann cells into the spinal cord of the myelin deficient rat. J Neurocytol 1988; 17: 351-360.
17. Gout O, Gansmuller A, Baumann N, Gumpel M. Remyelination by transplanted oligodendrocytes of a demyelinated lesion in the spinal cord of the adult shiverer mouse. Neurosci Lett 1988; 87: 195-199.
18. Warrington A, Barbarese E, Pfeiffer S. Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts. J Neurosci Res 1993; 34: 1-13.
19. Groves A et al. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 1993; 362: 453-455.
20. Barres B, Schmid R, Sendtner M, Raff M. Multiple extracellular signals required for long-term oligodendrocyte survival. Development 1993; 118: 283-295.
21. Barres B et al. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 1994; 367: 371-375.
22. Gage FH, Kawaja MD, Fisher LJ. Genetically modified cells: applications for intracerebral grafting. Trends Neurosci 1991; 14: 328-333.
23. Betsholtz C et al. cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature 1986; 320: 695-699.
24. Gunning P et al. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc Natl Acad Sci USA 1987; 84: 4831-4835.
25. Chen L, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7: 2745-2752.
26. Peterson C, Legerski R. High-frequency transformation of human repair-deficient cell lines by an Epstein-Barr virus-based cDNA expression vector. Gene 1991; 107: 279-284.
27. Ijichi A, Sakuma S, Tofilon PJ. Hypoxia-induced vascular endothelial growth factor expression in normal rat astrocyte cultures. Glia 1995; 14: 87-93.
28. Eisenbarth G, Walsh F, Nirenberg M. Monoclonal antibody to a plasma membrane antigen of neurons. Proc Natl Acad Sci USA 1979; 76: 4913-4917.
29. Raff M et al. Galactocerebroside is a specific cell-surface antigen marker for oligodendrocytes in culture. Nature 1978; 274: 813-816.